Top 11 enterobacter cloacae treatment in 2022

Below are the best information and knowledge on the subject enterobacter cloacae treatment compiled and compiled by our own team alltopus:

1. Enterobacter Infections

Author: www.ncbi.nlm.nih.gov

Date Submitted: 04/23/2020 01:36 PM

Average star voting: 4 ⭐ ( 73443 reviews)

Summary: Enterobacter is a genus belonging to the family of Enterobacteriaceae that is associated primarily with healthcare-related infections. There are currently 22 species of Enterobacter. However, not all species are known to cause human disease. Enterobacter species are responsible for causing many nosocomial infections, and less commonly community-acquired infections, including urinary tract infections (UTI), respiratory infections, soft tissue infections, osteomyelitis, and endocarditis, among many others. Certain species of this bacterium can be part of the microflora of the mammalian gastrointestinal tract, while other Enterobacter species can be present in human skin surfaces, water, certain foods, soil, and sewage.

Match with the search results: Carbapenems have been shown to be the most potent treatments for multidrug-resistant Enterobacter infections. …. read more

Enterobacter Infections

2. Cefepime vs Other Antibacterial Agents for the Treatment of Enterobacter Species Bacteremia

Author: academic.oup.com

Date Submitted: 04/12/2021 10:13 PM

Average star voting: 5 ⭐ ( 77580 reviews)

Summary: Among all cases of Enterobacter bacteremia at 2 academic hospitals over 6 years, we found 100% efficacy of single-agent cefepime at clearing bacteremia ≤1 day a

Match with the search results: Background. Carbapenems are recommended for treatment of Enterobacter infections with AmpC phenotypes. Although isolates are typically susceptible to cefepime ……. read more

Cefepime vs Other Antibacterial Agents for the Treatment of Enterobacter Species Bacteremia

3. Enterobacter Infections Medication: Antibiotics

Author: emedicine.medscape.com

Date Submitted: 12/01/2019 10:25 PM

Average star voting: 4 ⭐ ( 50016 reviews)

Summary: Enterobacter infections can include bacteremia, lower respiratory tract infections, skin and soft-tissue infections, urinary tract infections (UTIs), endocarditis, intra-abdominal infections, septic arthritis, osteomyelitis, CNS infections, and ophthalmic infections. Enterobacter infections can necessitate prolonged hospitalization, multiple …

Match with the search results: Carbapenems continue to have the best activity against E cloacae, E aerogenes, and other Enterobacter species. … They are not affected by ESBLs….. read more

Enterobacter Infections Medication: Antibiotics

4. Enterobacter Infections Treatment & Management: Approach Considerations, Medical Care, Surgical Care

Author: emedicine.medscape.com

Date Submitted: 04/30/2021 08:10 PM

Average star voting: 4 ⭐ ( 35342 reviews)

Summary: Enterobacter infections can include bacteremia, lower respiratory tract infections, skin and soft-tissue infections, urinary tract infections (UTIs), endocarditis, intra-abdominal infections, septic arthritis, osteomyelitis, CNS infections, and ophthalmic infections. Enterobacter infections can necessitate prolonged hospitalization, multiple …

Match with the search results: With few exceptions, the major classes of antibiotics used to manage infections with the E cloacae complex include the beta-lactams, carbapenems ……. read more

Enterobacter Infections Treatment & Management: Approach Considerations, Medical Care, Surgical Care

5. Frontiers | Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment | Microbiology

Author: www.frontiersin.org

Date Submitted: 08/07/2019 01:39 PM

Average star voting: 4 ⭐ ( 92371 reviews)

Summary: Enterobacter aerogenes and E. cloacae have been reported as important opportunistic and multiresistant bacterial pathogens for humans during the last three decades in hospital wards. These Gram-negative bacteria have been largely described during several outbreaks of hospital-acquired infections in Europe and particularly in France. The dissemination of Enterobacter spp is associated with the presence of redundant regulatory cascades that efficiently control the membrane permeability ensuring the bacterial protection and the expression of detoxifying enzymes involved in antibiotic degradation/inactivation. In addition, these bacterial species are able to acquire numerous genetic mobile elements that strongly contribute to antibiotic resistance. Moreover, this particular fitness help them to colonize several environments and hosts and rapidly and efficiently adapt their metabolism and physiology to external conditions and environmental stresses. Enterobacter is a versatile bacterium able to promptly respond to the antibiotic treatment in the colonized patient. The balance of the prevalence, E. aerogenes versus E. cloacae, in the reported hospital infections during the last period, questions about the horizontal transmission of mobile elements containing antibiotic resistance genes e.g. the efficacy of the exchange of resistance genes Klebsiella pneumoniae to Enterobacter spp. It is also important to mention the possible role of antibiotic use in the treatment of bacterial infectious diseases in this E. aerogenes / E. cloacae evolution.

Match with the search results: Imipenem remains the most effective molecule for treating E. cloacae infections. Since then, various ESBL of TEM, SHV, and CTX -M types have ……. read more

Frontiers | Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment | Microbiology

6. Enterobacter cloacae: symptoms | transmission | treatment |

Author: www.hygiene-in-practice.com

Date Submitted: 01/09/2021 02:08 PM

Average star voting: 3 ⭐ ( 45024 reviews)

Summary: Enterobacter cloacae is a bacterium of the genus Enterobacter and a natural component of the human intestinal flora.

Match with the search results: Enterobacter cloacae is a bacterium of the genus Enterobacter and a natural component of the human intestinal flora….. read more

Enterobacter cloacae: symptoms | transmission | treatment |

7. Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case–control study – Antimicrobial Resistance & Infection Control

Author: www.antimicrobe.org

Date Submitted: 08/03/2019 06:11 AM

Average star voting: 5 ⭐ ( 22107 reviews)

Summary: Enterobacter spp. possess chromosomal AmpC beta-lactamases that may be expressed at high levels. Previous studies have demonstrated a risk of relapsed bacteraemia following therapy with third generation cephalosporins (3GCs). What additional factors predict microbiological failure in Enterobacter bacteraemia is unclear. We aimed to determine factors associated with microbiological failure in Enterobacter bacteraemia. We retrospectively identified cases of bacteraemia caused by Enterobacter spp. occurring in four hospitals. Using a case–control design, we determined clinical risk factors for persistence or relapse defined as repeated positive blood cultures collected between 72 hours and up to 28 days post initial positive blood culture. During the study period a total of 922 bacteraemia events caused by Enterobacter spp. in adults were identified. The overall risk of relapsed or persisting bacteraemia at 28 days was low (31 of 922, 3.4%), with only 2 patients experiencing emergent resistance to 3GCs. A total of 159 patients were included in the case–control study. Using multivariate logistic regression, independent predictors for relapse were a line-associated source of infection (OR 3.87; 95% CI 1.56-9.60, p = 0.004) and the presence of immunosuppression (OR 2.70; 95% CI 1.14-6.44, p = 0.02). On univariate analysis definitive therapy with a broad-spectrum beta-lactam-beta-lactamase inhibitor (BLBLI, e.g. piperacillin-tazobactam) was not associated with relapse (OR 1.83; 95% CI 0.64-5.21, p = 0.26) although the proportion of patients receiving a BLBLI as definitive therapy was relatively small (21/159, 13.2%). The risk of relapsed or persistent Enterobacter bacteraemia appears to be low in Australia. A line-associated source of infection and immunocompromise were significant independent predictors for relapse. Larger, preferably randomized, studies are needed to address whether BLBLIs represent an effective carbapenem-sparing option for Enterobacter bacteraemia.

Match with the search results: The major species areEnterobacter cloacae, E. aerogenes and E. agglomerans. … in the treatment of gram negative infections in general, and Enterobacter in ……. read more

Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case–control study - Antimicrobial Resistance & Infection Control

8. Enterobacter Cloacae – an overview | ScienceDirect Topics

Author: aricjournal.biomedcentral.com

Date Submitted: 06/15/2020 07:41 AM

Average star voting: 3 ⭐ ( 26577 reviews)

Summary:

Match with the search results: Most significant Enterobacter infections are treated with agents … The most common species identified was Enterobacter cloacae (76.7%)….. read more

Enterobacter Cloacae - an overview | ScienceDirect Topics

9. Enterobacteriaceae

Author: www.sciencedirect.com

Date Submitted: 12/09/2019 09:17 AM

Average star voting: 5 ⭐ ( 53035 reviews)

Summary:

Match with the search results: Ceftriaxone and ceftazidime have been used in the treatment of brain abscess,173,174 although only a few patients have been studied. Ampicillin-sulbactam has ……. read more

Enterobacteriaceae

10. Inhibition of Enterobacter cloacae and Klebsiella oxytoca by Garlic (Allium sativum L.) and Garlic Pills ~ Fulltext

Author: www.infectiousdiseaseadvisor.com

Date Submitted: 05/12/2019 07:03 PM

Average star voting: 3 ⭐ ( 13001 reviews)

Summary: Inhibition of Enterobacter cloacae and Klebsiella oxytoca by Garlic (Allium sativum L.) and Garlic Pills

Match with the search results: Oral treatment options for ESBL-containing strains are limited to fosfomycin and nitrofurantoin as the best empirical choices for some types of urinary tract ……. read more

Inhibition of Enterobacter cloacae and Klebsiella oxytoca by Garlic (Allium sativum L.) and Garlic Pills ~ Fulltext

11. Enterobacter cloacae: Bacteremia, Epidemiology, and Antibiotic Resistance on JSTOR

Author: www.msdmanuals.com

Date Submitted: 02/02/2020 08:07 PM

Average star voting: 4 ⭐ ( 95002 reviews)

Summary: Joseph F. John, Jr., Robert J. Sharbaugh, Edward R. Bannister, Enterobacter cloacae: Bacteremia, Epidemiology, and Antibiotic Resistance, Reviews of Infectious Diseases, Vol. 4, No. 1 (Jan. – Feb., 1982), pp. 13-28

Match with the search results: Carbapenems have been shown to be the most potent treatments for multidrug-resistant Enterobacter infections. …. read more

Enterobacter cloacae: Bacteremia, Epidemiology, and Antibiotic Resistance on JSTOR

Related Posts

Leave a Reply

Your email address will not be published.